The price of a drug should be based on its therapeutic benefits – not just what the market will bear
Nicole Hassoun, Binghamton University, State University of New York The average price for an orphan…
Browsing: USA
ECCO 2017: Rising melanoma death rates could be blunted by new therapies by 2050
By 2050 the death rates from malignant melanoma will have decreased from their current levels…